跳至主要内容
临床试验/NCT04333082
NCT04333082已完成不适用

Refractory Status Epilepticus Treatment (RESET): Quality and Efficacy of Coma Induction

University Hospital, Basel, Switzerland1 个研究点 分布在 1 个国家目标入组 147 人开始时间: 2020年4月22日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
147
试验地点
1
主要终点
number of in- hospital death

研究概览

简要总结

This study is to investigate the effects of different treatment characteristics regarding the use of intravenous anesthetic drugs (IVADs) as a rescue treatment for refractory Status epilepticus (RSE) on course and outcome. A retrospective data extraction from the digital medical records, the electroencephalographic and microbiologic database of all consecutive adult patients with Status epilepticus (SE) admitted to the University Hospital Basel is undertaken.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Retrospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • diagnosed SE between 2005 and 2019 who have been treated at intensive care units (ICUs) of the University Hospital of Basel

排除标准

  • Patients with repetitive epileptic seizures not qualifying for SE or RSE
  • Patients with documented refusal of the general in-house consent

结局指标

主要结局

number of in- hospital death

时间窗: at baseline (T0)

number of in- hospital death

次要结局

  • neurofunctional alteration assessed by Glasgow Outcome Score (GOS)(at baseline (T0))

研究者

发起方
University Hospital, Basel, Switzerland
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验